Register for email alerts and news feeds:
This journal | BMJ Group
rss
Published Online First: 3 November 2005. doi:10.1136/ard.2005.045641
Annals of the Rheumatic Diseases 2006;65:728-735
Copyright © 2006 BMJ Publishing Group Ltd & European League Against Rheumatism.

EXTENDED REPORT

Anti-inflammatory effects of leflunomide in combination with methotrexate on co-culture of T lymphocytes and synovial macrophages from rheumatoid arthritis patients

M Cutolo1, S Capellino1, P Montagna1, A Sulli1, B Seriolo1, B Villaggio2

1 Research Laboratory and Division of Rheumatology, Department of Internal Medicine, University of Genoa, Genoa, Italy
2 Research Laboratory and Division of Nephrology, Department of Internal Medicine, University of Genoa, Genoa, Italy

Correspondence to:
Professor Maurizio Cutolo
Research Laboratory and Division of Rheumatology, Department of Internal Medicine, University of Genoa, Viale Benedetto XV, 6 - 16132 Genoa, Italy; mcutolo{at}unige.it

Objectives: To investigate the anti-inflammatory effects of the active leflunomide metabolite A771726 (Lef-M) in combination with methotrexate (MTX) on synovial macrophages (SM) from rheumatoid arthritis (RA) patients co-cultured with an activated T cell line (Jurkat cell line).

Methods: Pro-inflammatory cytokines (TNF{alpha}, IL1ß, IL6), adhesion molecule ICAM-1, cyclooxygenase isoenzymes (COX1, COX2), and the nuclear factor {kappa}B (NF-{kappa}B) complex were analysed on SM co-cultured with a T cell line, as intracellular protein expression by immunocytochemistry (ICC) and western blot analysis, as extracellular protein expression by ELISA assay, and as mRNA expression by reverse transcriptase-multiplex PCR (RT-MPCR) after treatment with Lef-M (1, 10, 30 µmol/l) alone or in combination with MTX (50 ng/ml).

Results: The most significant intracellular decrease in cytokines was observed by ICC in SM treated with the combination of Lef-M (1, 10, 30 µmol/l) and MTX (50 ng/ml) versus untreated SM (TNF{alpha} 29%, 37%, 49%, IL1ß 56%, 43%, 50%, and IL6 59%, 62%, 71%, respectively). Furthermore, a significant decrease was confirmed concerning cytokine levels evaluated by ELISA in the medium of SM treated with the combination Lef-M+MTX (TNF{alpha} 40%, 41%, 44%; IL1ß 10%, 20%, 60%; IL6 37%, 41%, 49%, respectively). Western blot and RT-PCR analysis confirmed these results. Concordant decreased expression was observed for ICAM-1, COX1, COX2, and the NF-{kappa}B complex after Lef-M+MTX treatment.

Conclusions: The combination of MTX and Lef-M shows additive inhibitory effects on the production of inflammatory mediators from SM co-cultured with a T cell line. These observations might support the positive results obtained in RA clinical studies by combination therapy.

Abbreviations: DHODH, dihydro-orotate dehydrogenase; DPBS, Dulbecco’s phosphate buffered saline; DRMRI, dynamic gadolinium enhanced magnetic resonance imaging; ICC, immunocytochemistry; Lef, leflunomide; Lef-M, leflunomide metabolite; MCP-1, monocyte derived chemokine; MDC-1, macrophage derived chemokine; MTX, methotrexate; NF-{kappa}B, nuclear factor {kappa}B; PBMC, peripheral blood mononuclear cells; RA, rheumatoid arthritis; RT-MPCR, reverse transcriptase-multiplex PCR; SD, standard deviation; SM, synovial macrophages

Keywords: leflunomide; macrophages; methotrexate; rheumatoid arthritis; TNF{alpha}


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Hueber, W., Tomooka, B. H, Zhao, X., Kidd, B. A, Drijfhout, J. W, Fries, J. F, van Venrooij, W. J, Metzger, A. L, Genovese, M. C, Robinson, W. H (2007). Proteomic analysis of secreted proteins in early rheumatoid arthritis: anti-citrulline autoreactivity is associated with up regulation of proinflammatory cytokines. Ann Rheum Dis 66: 712-719 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

BMJ Careers - Latest Rheumatology Jobs

Rheumatology Jobs